Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently... see more

OTCPK:ARLZQ - Post Discussion

View:
Post by kuatolives on Aug 12, 2016 10:40am

Maybe

Maybe we'll get some of those Concordia investor dollars. -24% today. Eeesh.
Comment by GoldenDilemma on Aug 12, 2016 9:28pm
Concordia is toast. Finito. 
Comment by kuatolives on Aug 13, 2016 7:16pm
That might be good news for ARLZ. With these bozo ponzi rollups on their way to their graves, an event like a drug approval *cough* might actually be viewed as something much more positive to Mr. Market than yet another debt fueled acquisition - perhaps much more than a year ago. If you're bored, go listen to the Concordia conference call and then compare that to the latest call from ARLZ ...more  
Comment by GoldenDilemma on Aug 13, 2016 10:43pm
Adrian Adams has conducted himself very well during the confrence calls.  Thompson on the other hand does not deliver the same professionalism IMO.  In any case, it is a sad case for CXR/CXRX longs who are still underwater. Once Cohodes and his gang went full force the only way was to be short against Concordia. And, still, they have no support till $7.50 zone. Let it fall some more ...more  
Comment by GoldenDilemma on Aug 13, 2016 10:58pm
(speaking of CXRX chart... and I would imagine that $7.50 zone will be toast)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities